Pfizer and Novo Nordisk’s battle over Metsera

Pfizer and Novo Nordisk have locked horns in a bidding war over Metsera – a US-based biotech in the process of developing new hormone-mimicking weight loss treatments originally spun out of Imperial College London, UK. Pfizer has filed two lawsuits trying to block novo from muscling in on its agreed deal with Metsera.